Case Background
A Connecticut jury delivered a $15 million verdict in favor of Evan Plotkin, a man who developed mesothelioma after decades of exposure to Johnson & Johnson's Baby Powder. The case, filed in the Superior Court of Connecticut, Judicial District of Fairfield at Bridgeport under Docket No. FBT-CV-21-6109520-S, concluded on October 15, 2024.
Cause
Evan C. Plotkin, a Connecticut resident, was exposed to asbestos and asbestos-containing products over several decades, from the 1950s through the 2000s. His exposure primarily resulted from his personal use of talcum products that contained asbestos, which he applied on himself and his children. Additionally, as an artist and sculptor, Plotkin regularly used asbestos-containing art and craft supplies during his work, further increasing his risk of exposure. This consistent and prolonged exposure occurred at various locations and times throughout his life. The Defendants, consisting of several companies involved in the asbestos industry, mined, milled, processed, manufactured, and distributed these asbestos-containing products. Despite their extensive involvement in the asbestos industry, the Defendants knew or should have known the dangers of asbestos exposure. By the 1920s, medical and scientific data clearly indicated that asbestos could cause severe health risks, including fatal diseases such as mesothelioma. Despite this knowledge, the Defendants continued to manufacture, market, and sell asbestos-laden products without providing adequate warnings to consumers. Throughout the 1950s, 1960s, and beyond, the Defendants actively concealed the hazardous nature of asbestos, withholding crucial information from the public and regulatory agencies. The products Plotkin used, including talcum powders, contained asbestos fibers that he inhaled and ingested. Over time, these fibers caused significant damage to his lungs, leading to the development of asbestos-related diseases, including mesothelioma. The Defendants failed to inform consumers of the deadly risks associated with asbestos exposure and took no steps to recall or reformulate their products.
Injury
Plotkin developed malignant mesothelioma, a fatal cancer caused by asbestos exposure. The disease caused severe physical pain, mental anguish, and emotional trauma. His life span was shortened, and his ability to work and enjoy family life was significantly impaired.
Damages Sought
The Plaintiffs sought compensatory damages for medical expenses, lost earning capacity, pain and suffering, and loss of enjoyment of life. They also pursued punitive damages under Connecticut law, alleging that the Defendants acted with reckless disregard for consumer safety.
Key Arguments and Proceedings
Legal Representation
· Plaintiff(s): Evan Plotkin | Martha Plotkin
· Counsel for Plaintiff: Brian P. Kenney | Benjamin Braly | Ethan A. Horn | Dana Casselli Simon
· Experts for Plaintiff(s): Arnold R. Brody| William Longo | Steven Haber | R. Mark Bailey | Gary Crakes | David Madigan
· Defendant(s): Johnson & Johnson | Johnson & Johnson Consumer Inc. f/k/a Johnson & Johnson Consumer Companies, Inc. | American International Industries, individually and as successor to Pinaud, Inc. | Barbara Alice, Inc., Ed. Pinaud, Inc. d/b/a Ed. Pinaud, and Nestle-Le Mur Company | Brenntag North America, Inc., individually and as successor-in-interest to Mineral and Pigment Solutions, Inc. and Whittaker, Clark & Daniels, Inc. | Brenntag Specialties, LLC f/k/a Brenntag Specialties, Inc. f/k/a Mineral and Pigment Solutions, Inc., successor-in-interest to Whittaker, Clark & Daniels, Inc. | Connecticut CVS Pharmacy, L.L.C. | CVS Health Corporation | CVS Pharmacy, Inc. | Glamour Industries Co. | Kerr Corporation | The Neslemur Company f/k/a The Nestle-Lemur Company | Whittaker, Clark & Daniels, Inc. | Chattem, Inc. | S & S Brands LLC | Pfizer Inc. | Johnson & Johnson Holdco (NA) Inc. f/k/a Johnson & Johnson Consumer Inc., individually and successor in interest to Johnson & Johnson Subsidiary "Old JJCI" | Kenvue Inc., individually and as successor in interest to Johnson & Johnson Consumer Inc. | Janssen Pharmaceuticals, Inc., individually and as successor in interest to Johnson & Johnson Subsidiaries named Johnson & Johnson Consumer Inc., both prior to and after its 2021 restructurings and colloquially known as "Old JJCI" and "New JJCI" | LTL Management, Inc. | Pecos River Talc LLC
· Counsel for Defendants: Jenny D. DeFrancisco, Esq.| Carlton Fields P.A.P.C., | Wm Tucker Griffith | Carlie Shane Seigal | Meghan L. Riordan | Judith A. Perritano | Robert E. Thackston | Christopher S. Kozak | Paula Pendley | James Paul Kerr | James F. Murdica | McElroy Deutsch | Christine Marie Delaney | Diane H. Miller | Brittany M. Barbet | Andrew Jay Kornblau | Kevin W. Hadfield | William W. Oxley | Kelly Meghan Rohling | Fatih Furkan Bayraktar
· Experts for Defendant(s): Robert Adams | Laura Fuchs Dolan | I.A. Feingold | Brooke T. Mossman | Kenneth Mundt | Tim D. Oury | Alan M. Segrave | Richard Attanoos | Christy Barlow | Michele Carbone | Lewis Chodosh | Brent Finley | Mark Wick | Gary M. Marsh | Dominik Alexander | David Weill
Claims
Product Liability and Strict Liability: The Plaintiffs argued that Johnson & Johnson's talc products were sold in a defective condition that was unreasonably dangerous to consumers. They claimed the company failed to warn users about the asbestos contamination despite knowing about it since at least 1969.
Negligence: The complaint alleged that the Defendants failed to use ordinary care in selling Johnson's Baby Powder. This included failure to test products properly, failure to remove dangerous products from the market, and failure to find safer alternatives.
Failure to Warn: Plotkin's legal team contended that Johnson & Johnson never placed warnings on its products about potential asbestos exposure or cancer risks, even though the company possessed medical and scientific data indicating these hazards since the 1920s.
Fraud and Concealment: The Plaintiffs presented evidence that Johnson & Johnson deliberately hid laboratory test results showing asbestos in their talc products. Internal company documents revealed that J&J instructed testing laboratories to destroy records and manipulated testing protocols to produce false negative results.
CUTPA Violation: The lawsuit included a claim under the Connecticut Unfair Trade Practices Act, alleging that Johnson & Johnson's marketing practices were deceptive and caused substantial injury to consumers.
Defense
The Defendants denied all allegations and asserted multiple special defenses. They argued that Plotkin's injuries resulted from the negligence of other parties, that he failed to use the products properly, and that the discovery of any potential danger was beyond the state of scientific knowledge at the time. The defense also claimed that Plotkin assumed the risks associated with product use and failed to mitigate his damages. Johnson & Johnson maintained that their products conformed to prevailing industry standards and regulations.
Successor Liability
The jury addressed whether Kenvue Inc. and Johnson & Johnson Holdco (NA) Inc. were successors-in-interest to Johnson & Johnson and Johnson & Johnson Consumer Inc. The jury found that both entities continued the business of the original companies and continued manufacturing the same talc products that allegedly caused Plotkin's injury.
Jury Verdict
On October 15, 2024, the jury returned a verdict in favor of Evan Plotkin against all five Defendants: Johnson & Johnson, Pecos River Talc LLC, Johnson & Johnson Holdco (NA) Inc., Kenvue Inc., and LLT Management LLC.
The jury found that the Plaintiffs proved their claims by a fair preponderance of the evidence. All Defendants were found liable under strict liability, negligence, and failure to warn theories. The jury determined that product defects and negligence by each Defendant were the proximate cause of Plotkin's mesothelioma.
The jury awarded $15 million in compensatory damages for the injuries sustained by Evan Plotkin. The jury found no failure by Plotkin to mitigate his damages.
The jury also determined that punitive damages were warranted against all five Defendants, finding that Johnson & Johnson and its successor entities acted with reckless disregard for consumer safety.
